Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

Journal: Science

Published: 2019-12-06

DOI: 10.1126/science.aay7199

Affiliations: 13

Authors: 35

Go to article
Institutions Share
Duke Human Vaccine Institute (DHVI), United States of America (USA) 0.32
Duke Department of Medicine, United States of America (USA) 0.28
Program in Cellular and Molecular Medicine (PCMM), BCH, United States of America (USA) 0.09
Harvard Department of Genetics, United States of America (USA) 0.09
KU Department of Chemistry, United States of America (USA) 0.06
Duke Department of Surgery, United States of America (USA) 0.04
NIH NIEHS Genome Integrity and Structural Biology Laboratory, United States of America (USA) 0.03
U.S. Department of Health and Human Services (HHS), United States of America (USA) 0.03
3M Company, United States of America (USA) 0.03
Bioqual, Inc., United States of America (USA) 0.03
Duke Department of Immunology, United States of America (USA) 0.02
Duke Department of Molecular Genetics and Microbiology, United States of America (USA) 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER